Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$108.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 5 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 155 business days late.
The 13 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Jan 6 | PMCB | PharmaCyte Biotech, Inc. | PBUY | 20,000 | $0.7904 | $15.8K | +13.1% | Open the original filing on SEC.gov |
| Jan 5 | PMCB | PharmaCyte Biotech, Inc. | PBUY | 20,000 | $0.7776 | $15.6K | +15.1% | Open the original filing on SEC.gov |
| Dec 12, 2025 | PMCB | PharmaCyte Biotech, Inc. | FTAX | 67,500 | $1.02 | $68.9K | -33.8% | Open the original filing on SEC.gov |
| Dec 12, 2025 | PMCB | PharmaCyte Biotech, Inc. | AGRANT | 150,000 | — | — | +300.0% | Open the original filing on SEC.gov |
| Nov 14, 2025 | OBLG | Oblong, Inc. | PBUY | 10,000 | $1.91 | $19.1K | +66.7% | Open the original filing on SEC.gov |
| Sep 17, 2025 | OBLG | Oblong, Inc. | PBUY | 5,000 | $2.70 | $13.5K | +50.0% | Open the original filing on SEC.gov |
| Sep 16, 2025 | OBLG | Oblong, Inc. | PBUY | 10,000 | $2.73 | $27.3K | — | Open the original filing on SEC.gov |
| Aug 6, 2025 | TAOX | TAO Synergies Inc. | AGRANT◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 30, 2025 | TAOX | TAO Synergies Inc. | FTAX | 8,630 | $7.85 | $67.7K | -38.1% | Open the original filing on SEC.gov |
| Jun 30, 2025 | TAOX | TAO Synergies Inc. | AGRANT | 21,575 | — | — | +1,979% | Open the original filing on SEC.gov |
| Apr 25, 2025 | PMCB | PharmaCyte Biotech, Inc. | AGRANT◆ | 63,233 | — | — | — | Open the original filing on SEC.gov |